What is Praxis Precision Medicines Inc (PRAXus)?
Praxis Precision Medicines Inc is a biopharmaceutical company engaged in the discovery and development of precision therapies for neurological disorders. The company applies genetic and molecular research to identify novel targets and develop treatments aimed at addressing underlying causes of diseases such as epilepsy and other central nervous system conditions. Praxis Precision Medicines utilizes a precision medicine approach, integrating biomarkers and patient stratification in its drug development process. The company collaborates with academic institutions and research organizations to advance its pipeline. Its focus encompasses both small molecule and biologic therapeutics designed to improve patient outcomes in areas with significant unmet medical needs.
Praxis Precision Medicines Inc Stock Price Today: Live Overview
The price today is shaped by trading fluctuations, as Praxis Precision Medicines Inc trades at $294.66. The current session has seen prices move from $290.29 up to $315.95, with a daily change percentage of 0%.
FAQ: Praxis Precision Medicines Inc (PRAXus)
What is the current price of PRAXus stock?
The last recorded price is $294.66.
Does PRAXus pay dividends?
No dividends are paid by the company.
Does PRAXus have a formal corporate presence or regional headquarters in the UAE?
Praxis Precision Medicines Inc does not have an official presence in the UAE and operates through distributors.
What is PRAXus best known for?
Praxis Precision Medicines Inc is most famous for developing precision therapies for central nervous system disorders.
What assets are typically shown together with PRAXus?
Commonly shown alongside PRAXus: Standard Lithium Ltd, Viking Therapeutics, Inc., Millicom International Cellular SA
Latest shares articles



